Enavate's Zenas Pharma Footnote: Obexelimab Pipeline Watch
Inside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
Budget slips happen, but you can regain stability with a simple plan. Identify leaks, prioritize essentials, and set a realistic spending cap to regain confidence.
24,983 articlesInside ENAVATE's disclosed stake in Zenas BioPharma and why the Obexelimab pipeline is grabbing attention. Learn what...
When homes linger on the market, buyers gain negotiating power and lenders adjust terms. This guide explains how stal...
SoundHound AI shares slid about 13% in after-hours and Friday trading after a mixed Q1 2026 report that highlighted s...
A clear, investor-friendly breakdown of SRFM's Q1 2026 results. Learn what the srfm 2026 earnings transcript reveals ...
Citi lowers Lucid's price target to $14 following a disappointing Q1 2026 and the withdrawal of 2026 guidance, while ...
When a stock jumps in the morning, traders ask: what happened? This article explains why stock popped today can occur...
Vitalik Buterin announces a structural reset for the Ethereum Foundation to reduce selling pressure and sharpen gover...
Emerging renders point to a major Siri refresh: a standalone app, deeper Dynamic Island integration, and a Gemini-bas...
Considering Marvell Technology? This guide breaks down how to decide if should marvell stock today? makes sense for y...
A tiny 32 BTC sale by Saylor’s firm coincides with a wider pullback driven by major treasury holders and miner liquid...
Casey's General Stores stock jumped after a robust earnings report that topped expectations. This guide breaks down w...
SpaceX hits the public markets with a high-profile IPO, but the spacex president warning investors message underscore...